1 min read

Gene Therapy for Rare Disorders 2022 | Booth #22

Meet Veristat at the Gene Therapy for Rare Disorders Conference 2022 in Boston, MA -  March 7-10, 2022 at Booth 22


Veristat will be exhibiting and presenting at the 2022 Gene Therapy for Rare Disorders Conference. Our teams have worked on 110+ cell and gene therapy projects in the past 5 years - over 70% of them in rare disorders. No matter your need, our scientific experts are adept at both strategy and execution across the clinical development journey. 


Schedule a meeting using the form and attend our presentation, Operational Challenges of Natural History Trials to learn more.


Attend Our Presentation 

Title: Operational Challenges of Natural History Trials

Date & Time: March 8, 2022 at 2:30 PM ET


Hear Veristat experts discuss operational challenges of natural history trials for gene therapies, including:

  • Pivoting to a virtual and in-person hybrid trial model to benefit patients and sponsors alike during COVID-19 
  • Operationalization of a novel clinical trial design 
  • Case study examples of overcoming operational challenges for retrospective and prospective data collection in a pediatric, rare-disease population 
Veristat Speakers:

Kara Langer_Headshot                                   Kim MacDonnell_Headshot

Kara Langer                                                        Kim MacDonnell, BScN, MSc, RN, CGC

Senior Project Manager                              Lead Clinical Research Associate


Schedule A Meeting

Schedule a meeting by filling out the form on the right.   Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.


Conference Details

Website: https://genetherapy-conference.com/

Hynes Convention Center, Boston, MA

Share This Event:


1 min read

Biotechgate Digital Partnering 2023

Meet Veristat  during Biotechgate Digital PartneringNovember 27- December 1  

With nearly 30 years of experience in...

1 min read

DTRA 2023

Meet Veristat in Boston at DTRA  

With nearly 30 years of experience in clinical trial planning and execution for...